Alaunos Therapeutics (TCRT) Q1 2024 Annual Earnings
TCRT·Reported May 15, 2024·Before market open
Alaunos Therapeutics reported Q1 2024 revenue of $1.0K. Diluted EPS came in at $-1.10, beat the $-4.50 consensus by $3.40.
Revenue
$1.0K
Diluted EPS
$-1.10beat by $3.40
Consensus: $-4.50
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Alaunos Therapeutics's Q1 2024 earnings report.
Alaunos Therapeutics (TCRT) reported Q1 2024 earnings on May 15, 2024 before market open.
Alaunos Therapeutics reported revenue of $1.0K and diluted EPS of $-1.10 for Q1 2024.
EPS beat the consensus estimate of $-4.50 by $3.40.
You can read the 10-K periodic report (0000950170-24-038868) directly on SEC EDGAR. The filing index links above go to sec.gov.